Patents by Inventor Toshiomi Nakate

Toshiomi Nakate has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Suspendible composition and process for preparing the same
    Patent number: 5496564
    Abstract: A suspendible composition comprising a tricyclic compound such as FK 506 substance which is 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylviny l]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo-[22.3. 1.0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone, or the like, and a pharmaceutically acceptable surfactant, which can be used as an orally administrable agent or eye drops and is useful for treating various diseases.
    Type: Grant
    Filed: August 26, 1994
    Date of Patent: March 5, 1996
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Sotoo Asakura, Yasuto Koyama, Youhei Kiyota, Kiyoko Akashi, Akira Kagayama, Yoshio Murakami, Toshiomi Nakate
  • Ointments containing FK-506 or derivatives thereof
    Patent number: 5385907
    Abstract: An ointment comprising a tricyclic compound such as FK 506 substance which is 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylviny l]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1 .0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone, or the like, a solubilizing and/or absorption-promoting agent and an ointment base, which is useful for treating various skin diseases.
    Type: Grant
    Filed: May 17, 1993
    Date of Patent: January 31, 1995
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Sotoo Asakura, Yoshio Murakami, Nobuto Kanagawa, Toshiomi Nakate
  • Suspendible composition and process for preparing the same
    Patent number: 5368865
    Abstract: A suspendible composition comprising a tricyclic compound such as FK 506 substance which is 17-allyl-1,14-dihydroxy-12-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylviny 1]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1 .0.sup.4,9 ]octacos-18-ene-2,3,10,16-tetraone, or the like, and a pharmaceutically acceptable surfactant, which can be used as an orally administrable agent or eye drops and is useful for treating various diseases.
    Type: Grant
    Filed: July 27, 1993
    Date of Patent: November 29, 1994
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Sotoo Asakura, Yasuto Koyama, Youhei Kiyota, Kiyoko Akashi, Akira Kagayama, Yoshio Murakami, Toshiomi Nakate
  • Sustained-release percutaneous preparations
    Patent number: 4889721
    Abstract: Sustained-release percutaneous preparations which have at least two adhesive layers and in which a drug is contained in the layer farthest from the skin and a solid powder is dispersed in an adhesive layer other than the layer farthest from the skin provide slow release of the drug. By varying the kind and concentration of the solid powder, the rate of release of the drug from the preparations can be controlled.
    Type: Grant
    Filed: July 15, 1988
    Date of Patent: December 26, 1989
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Yoshio Ueda, Sotoo Asakura, Yoshio Murakami, Toshiomi Nakate